Finally, Darji highlights that animal studies suggest a potential link between GLP-1s and thyroid cancer
This leaves patients who could genuinely benefit without access
Researchers initially investigated it as a potential treatment for obesity and metabolic disorders
10.4103/2045-080X.183029 Sonthalia S, Jha AK, Lallas A, Jain G, Jakhar D: Glutathione for skin lightening: a regnant myth or evidence-based verity
Highlights: GLP-1 receptor agonists linked to 14 percent lower risk of developing substance use disorders Reduced risks observed across alcohol, cannabis, cocaine, nicotine and opioid disorders Patients with existing addiction experienced fewer overdoses, hospitalizations and deaths GLP-1 receptor agonist drugs commonly prescribed for type 2 diabetes mellitus and obesity may also be linked to lower risk of substance use disorders (SUD) , according to a large cohort study published in the journal BMJ (1 Trusted Source Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study
